Clinical trial

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients

NCT06224244

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-02-01

PhasePHASE2

Study timeline

Study start (actual)2022-02-01Date precision: day

Registry last updated2025-07-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Breast Cancerunresolved

Interventions

Ten-fraction hypofractionated breast radiotherapy with 40 Gy simultaneous integrated bed boostRADIATION

Ten-fraction hypofractionated breast radiotherapy with 43 Gy simultaneous integrated bed boostRADIATION

Sponsors & collaborators

Regina Elena Cancer Institutelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06224244 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.